开窗分支腔内修复胸腹主动脉瘤对肌少症发生的影响
单中心回顾性研究纳入2016—2022年接受开窗分支腔内修复(f/bEVAR)的103例胸腹主动脉瘤患者,按术前腰大肌面积分为肌少症组72例与非肌少症组31例。分期修复和慢性夹层可减少腰大肌丢失。
要点
- f/bEVAR术后1年非肌少症组腰大肌丢失更明显,45%降至阈值以下。
- 分期腔内修复和慢性主动脉夹层与随访期腰大肌丢失减少相关。
- 竖脊肌面积丢失两组相似,肌少症组脊髓缺血更常见。
核心结论
- 广泛主动脉覆盖的f/bEVAR术后第一年可检测到腰大肌和竖脊肌显著丢失。
研究设计与样本
- 单中心回顾性研究纳入2016—2022年接受f/bEVAR的103例I、II、III、V型胸腹主动脉瘤患者。
关键数值与推荐
- 术前腰大肌面积<350 cm2×HU定义为肌少症。
临床怎么用
- 个体化治疗规划可考虑分期手术,并持续评估肌少症状态以优化结局。
局限性
- 肌少症作为f/bEVAR术后死亡和主要不良事件分层工具的作用尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sarcopenia has been identified as an independent risk factor for mortality in thoracoabdominal aortic aneurysm (TAAA) patients treated with fenestrated and branched endovascular aortic repair (f/bEVAR). The aim of this study was to investigate the impact of f/bEVAR with extensive aortic coverage on the development of sarcopenia. METHODS: A single-center retrospective study was conducted including patients treated with f/bEVAR between 2016 and 2022. Preoperative computed tomography angiography and 1-year follow-up scans were used to measure lean psoas muscle area (LPMA, cm2 × Hounsfield units [HU]) and lean erector spinae muscle area (cm2 × HU) at the L3 vertebra level. A previously established cut-off value of preoperative LPMA was used to divide the patients into two groups: the sarcopenia group (SG; LPMA <350 cm2 × HU) and the no SG (NSG; LPMA ≥350 cm2 × HU). The primary outcome of this study was the development of sarcopenia after f/bEVAR. RESULTS: A total of 103 patients with types I, II, III, and V TAAAs were included (SG, n = 72; NSG, n = 31). SCI was more common in SG (24% vs 10%; P = .039). Three-year survival was 94 ± 3% with all four deaths occurring in the SG (P = .210). At 1 year after f/bEVAR, psoas muscle loss (LPMA loss, -24% vs -0.3%; P = .047) was more pronounced in the NSG, with 45% of the cases falling below the value of 350 cm3 × HU during the 12-month follow-up. Staged endovascular repair and chronic aortic dissection with fewer patent intercostal and lumbar arteries before f/bEVAR decreased LPMA loss during follow-up. For lean erector spinae muscle area, muscle loss was similar between groups (-27% vs -24%; P = .769). CONCLUSIONS: During the first year after f/bEVAR for TAAA, a significant loss of psoas and erector spinae muscle was detected after extensive aortic coverage. Individualized treatment planning with staged procedures and continued evaluation of sarcopenia status, including focused prevention and treatment of sarcopenia, could help to optimize outcomes. Further studies are needed to define the role of sarcopenia as a reliable stratification tool for mortality and major adverse events after f/bEVAR.
引用
- Enzmann FK, Nana P, Grandi A, et al. Impact of endovascular thoracoabdominal aortic aneurysm repair on the development of sarcopenia. J Vasc Surg. 2025. PMID: 41167385. doi:10.1016/j.jvs.2025.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。